Simcere Pharma Grants 15.4 million RSUs Under Incentive Scheme; Shares Slip 4%

MT Newswires Live
2025/12/02

Simcere Pharmaceutical Group (HKG:2096) agreed to grant over 15.4 million restricted share units (RSUs) to 97 participants under a 2021 incentive scheme, a Monday Hong Kong bourse filing said.

Shares of the pharmaceutical firm were down nearly 4% in Tuesday afternoon trading.

The RSUs represent the same number of underlying shares.

The grantees include certain executive directors, members of the senior management, and 92 other employees.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10